Ingrid Knape

Suggest Changes
Learn More
Genetically modified antigen-presenting cells (APC) represent an attractive strategy for in vitro immunomodulation. In the human system, APC expressing HLA-A1 and a membrane-bound form of CD95L(More)
  • 1